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Aged garlic has more potent 
antiglycation and antioxidant 
properties compared to fresh  
garlic extract in vitro
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Protein glycation involves formation of early (Amadori) and late advanced glycation endproducts 
(AGEs) together with free radicals via autoxidation of glucose and Amadori products. Glycation 
and increased free radical activity underlie the pathogenesis of diabetic complications. This study 
investigated whether aged garlic has more potent antiglycation and antioxidant properties compared 
to fresh garlic extract in vitro in a cell-free system. Proteins were glycated by incubation with sugars 
(glucose, methylglyoxal or ribose) ±5–15 mg/mL of aged and fresh garlic extracts. Advanced glycation 
endproducts were measured using SDS-PAGE gels and by ELISA whereas Amadori products were 
assessed by the fructosamine method. Colorimetric methods were used to assess antioxidant activity, 
free radical scavenging capacity, protein-bound carbonyl groups, thiol groups and metal chelation 
activities in addition to phenolic, total flavonoid and flavonol content of aged and fresh garlic extracts. 
Aged garlic inhibited AGEs by 56.4% compared to 33.5% for an equivalent concentration of fresh garlic 
extract. Similarly, aged garlic had a higher total phenolic content (129 ± 1.8 mg/g) compared to fresh 
garlic extract (56 ± 1.2 mg/g). Aged garlic has more potent antiglycation and antioxidant properties 
compared to fresh garlic extract and is more suitable for use in future in vivo studies.
Chronic hyperglycaemia of diabetes mellitus underlies the development of long-term complications afflicting the 
eyes, nerves, blood vessels, kidneys and skin of affected individuals. Hyperglycaemia increases protein glycation, 
which is the non-enzymatic reaction between carbonyl groups from reducing sugars and protein amino groups 
forming an unstable Schiff base that rearranges to a more stable Amadori product. Once formed, the Amadori 
products undergo further reactions involving dicarbonyl intermediates such as 3-deoxyglucosones and ultimately 
forming fluorescent and cross-linked structures called advanced glycation endproducts (AGEs). Accumulation 
of tissue AGEs have been implicated in the development of diabetic complications1,2. Protein glycation is accom-
panied by free radical production from autoxidation of glucose (autoxidative glycation) and oxidation of glycated 
proteins (glycoxidation) to from AGEs2. Free radicals are capable of damaging biomolecules and this oxidative 
stress contributes towards the pathogenesis of diabetic complications2.
Despite advances in treatment, the long-term complications of diabetes are a major cause of concern. Thus, 
inhibition of AGE-mediated tissue damage and oxidative stress may offer therapeutic potential for preventing or 
delaying onset or progression of diabetic complications1. Various antiglycation compounds have been studied and 
include aminoguanidine, a drug found to be effective both in vitro and in vivo1. Other compounds include AGE 
cross-link breakers such as N-phenacylthiazolium bromide have been proposed as agents for reversing protein 
cross-linking caused by AGEs3. Furthermore, there is considerable interest in compounds capable of blocking 
interaction between AGEs and their receptor called receptor for AGEs (RAGE)4. Although many compounds 
have been studied, none has been approved for clinical use. Whilst the search for new synthetic antiglycation 
agents continues, little attention has been devoted to antiglycation agents from natural sources. Various studies 
have indicated that dietary supplementation with nutrients possessing both antiglycation and antioxidant prop-
erties may be a safe and simple complement to traditional therapies aimed at preventing diabetic complications5.
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Garlic (Allium sativum) has been used as a flavouring agent, functional food and in folklore medicine. 
Indeed, its medicinal properties have been used to treat a wide variety of diseases since ancient times6. Garlic 
is a well-established prophylactic and therapeutic medicinal agent, which has been investigated for health ben-
efits, resulting in more than 3,000 publications from all over the world7. Garlic is a rich source of water- and 
lipid-soluble organosulphur compounds, but the constituents responsible for the health benefits of garlic may 
vary in type and concentration, depending on different processing, preparations and soil conditions8. Garlic is 
available in different formulations; one of which is aged garlic extract and manufactured by soaking sliced raw 
garlic in 15–20% aqueous ethanol for up to 20-months at room temperature. The extract is then filtered and 
concentrated under reduced pressure at low temperature. During this ageing, the odorous and harsh irritating 
compounds in garlic are converted to odourless, non-irritating, safe sulphur compounds9. This process causes 
loss of allicin and increases activity of other water-soluble organosulphur compounds, such as S-allyl cysteine 
(SAC), S-allyl mercaptocysteine (SAMC), allixin and selenium, all of which are antioxidants8,10. Another anti-
oxidant present in aged garlic extract is N-fructosyl arginine, which is not present in raw or heat-treated garlic 
preparations11. The aim of this study was to investigate and compare the abilities of aged and fresh garlic extracts 
to inhibit formation of AGEs. Furthermore, the antioxidant activity of aged garlic extract was also investigated 
and compared with that of fresh garlic extract.
Results
Effects of aged and fresh garlic extracts on cross-linked AGEs.  Glycation of lysozyme by glucose 
produces crosslinked AGEs that present as dimers with an approximate molecular weight of 28 kDa. Glycated 
lysozyme (Fig. 1A, lane b) showed reduced electrophoretic mobility for the lysozyme monomer and the presence 
of dimers formed via AGE crosslinks compared to native lysozyme (Fig. 1A, lane a). Aged garlic (Fig. 1A, lanes c–e) 
and fresh garlic extracts (Fig. 1A, lanes f–h) inhibited AGE-induced dimerization of lysozyme in a dose-depend-
ent manner. The mean values for aged garlic extract at 5, 10 and 15 mg/mL concentrations were 11.2%, 40.4% 
and 56.4%, compared to 5.9%, 24.9% and 33.5% for fresh garlic extract, respectively. Aged garlic extract showed 
a significantly (P < 0.01) greater inhibitory effect compared to fresh garlic extract at higher concentrations only 
(10–15 mg/mL) (Fig. 1B).
Amadorin activity of aged and fresh garlic extracts. Reincubation of dialysed Amadori-rich bovine 
serum albumin (BSA) following glycation with ribose results in the formation of AGEs as shown in Fig. 2. The 
kinetics of post-Amadori AGE formation was rapid over 2 days in the absence of any inhibitors. Both aged and 
fresh garlic extracts inhibited these post-Amadori reactions with aged garlic extract being more effective at all 
Figure 1. (A) SDS-PAGE gel showing the effects of aged and fresh garlic extracts on formation of crosslinked 
AGEs formed by glycation of lysozyme (10 mg/mL) by 0.5 M glucose in 0.1 M phosphate buffer, pH 7.4 for 4 
weeks at 37 °C. Unmodified lysozyme (lane a), glycated lysozyme (lane b) or lysozyme glycated in the presence 
of 5 (lane c), 10 (lane d) or 15 mg/mL (lane e) of aged garlic extract or 5 (lane f), 10 (lane g) or 15 mg/mL  
(lane h) of fresh garlic extract. (B) Percentage inhibition of crosslinked AGEs. Each value represents the 
mean ± SD (n = 3). Statistical significance was defined as **P < 0.01 compared to aged garlic extract.
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concentrations tested compared to glycated BSA. At low concentrations (5 mg/mL), aged garlic extract showed no 
significant inhibition of post-Amadori AGE formation compared to fresh garlic extract (Fig. 2A). From the data 
in Fig. 2B and C, it is apparent that aged garlic extract at higher concentrations (10–15 mg/mL) showed significant 
(P < 0.001) inhibition of post-Amadori AGE formation after 8 days compared to fresh garlic extract.
Effect of aged and fresh garlic extracts on fructosamine formation.  An increase in fructosamine 
occurs following incubation of BSA with glucose but not for BSA incubated alone (Fig. 3). Both extracts inhibited 
fructosamine production after 2 and 8 days of incubation with aged garlic being more effective compared to fresh 
garlic extract (Fig. 3). Compared to the glycated BSA, aged garlic extract showed significant (P < 0.001) inhibition 
in fructosamine formation after 2 and 8 days. Similarly, fresh garlic extract showed a significant (P < 0.01) inhibi-
tion of fructosamine formation. Fructosamine formation was inhibited more by aged garlic extract than by fresh 
garlic extract on day 8 (P < 0.01) but not on day 2 (Fig. 3).
Effect of aged and fresh garlic extracts on glycation-induced protein carbonyl and thiol group 
formation. Bovine serum albumin glycated for 4 days showed an increase in protein bound carbonyl groups 
compared to BSA alone as a negative control (Table 1). Both extracts inhibited formation of protein-bound car-
bonyl groups with aged garlic extract being more effective (Table 1). Compared to glycated BSA, aged garlic 
extract showed significant (P < 0.001) inhibition of carbonyl group formation. Similarly, fresh garlic extract 
showed significant (P < 0.01) inhibition of carbonyl group formation. Glycated BSA had a significantly 
(P < 0.001) lower thiol content compared to BSA alone. Aged garlic extract had a significant (P < 0.001) pro-
tective effect against oxidation of thiol groups and fresh garlic extract also showed a significant (P < 0.01) effect 
Figure 2. Effect of (A) 5 mg/ml, (B) 10 mg/ml and (C) 15 mg/ml of aged and fresh garlic extracts on post-
Amadori AGE formation measured using ELISA at different time points. Results are presented as mean ± SD 
(n = 3). At each time interval, statistical significance was defined as *P < 0.05, **P < 0.01, ***P < 0.001 compared 
to fresh garlic extract.
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compared to glycated BSA. Aged garlic extract was significantly (P < 0.05) more effective than fresh garlic extract 
in the prevention of thiol group oxidation (Table 1).
Antioxidant activities of aged and fresh garlic extracts. In the 2, 2-azino-bis 3–ethylbenzthiazo-
line–6–sulfonic acid or ABTS assay, both extracts displayed antioxidant activities, as they were able to scavenge 
the ABTS+. Aged garlic extract had a higher Trolox equivalent antioxidant capacity (TEAC) compared to fresh 
garlic extract (Table 2). There was no significant difference in TEAC between aged garlic extract and ascorbic 
acid. However, fresh garlic extract showed a significant (P < 0.001) difference in TEAC compared to ascorbic 
acid. Aged garlic extract had a protective effect and significantly (P < 0.001) reduced TEAC compared to fresh 
garlic extract. In the 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging assay, ascorbic showed signifi-
cant (P < 0.001) inhibition of DPPH radicals compared to aged and fresh garlic extracts. The effect of aged garlic 
extract was significantly (P < 0.001) different from fresh garlic extract. Indeed, aged garlic extract demonstrated 
a stronger DPPH scavenging ability than fresh garlic extract (Table 2).
Figure 3. Effects of 10 mg/mL aged and fresh garlic extracts on fructosamine formation. BSA (10 mg/mL) 
was glycated by 0.5 M glucose in 0.1 M phosphate buffer, pH 7.4 for 10 days at 37 °C. Each value represents 
the mean ± SD (n = 3). At each time interval, statistical significance was defined as **P < 0.01, ***P < 0.001 
compared to glycated BSA.
Carbonyl groups 
nmol/mg protein
Thiol groups 
pmol/mg protein
BSA 0.4 ± 0.2 11.4 ± 0.9
Glycated BSA in absence 
of extracts 12
C ± 0.4 5C ± 0.2
Glycated BSA in 
presence of aged garlic 
extract
5.9Ab ± 0.5 9.4Ab ± 0.5
Glycated BSA in 
presence of fresh garlic 
extract
8.3Ba ± 0.6 8Ba ± 0.5
Table 1.  Effects of 10 mg/mL aged and fresh garlic extracts on protein carbonyl and thiol groups of 
methylglyoxal- and glucose-modified BSA respectively. Data are presented as mean ± SD (n = 6). The 
symbols A and B refer to the significant difference between labelled values as compared to the glycated BSA in 
the absence of extracts. Labelled means in each column without common uppercase letters differ significantly 
from glycated-BSA, P < 0.001 and P < 0.01 respectively. Labelled means in each column without common 
lowercase letters differ significantly from aged garlic extract, P < 0.05.
ABTS [TEAC]  
(μM Trolox)
DPPH [IC50]  
(mg/mL)
Ascorbic acid 19.5C ± 0.3 11.7C ± 0.2
Aged garlic extract 19Cb ± 0.1 15Ab ± 0.2
Fresh garlic extract 12Aa ± 0.7 24Ba ± 0.5
Table 2.  Antioxidant activities of ascorbic acid, aged garlic and fresh garlic extracts as determined by 
ABTS and DPPH radical scavenging assays.  Data are presented as mean ± SD (n = 6). The symbol A and B 
refer to the significant difference between the labelled values as compared to the ascorbic acid. Labelled means 
in each column without common uppercase letters differ significantly from ascorbic acid, P < 0.001. Labelled 
means in each column without common lowercase letters differ significantly from aged garlic extract, P < 0.001.
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Metal chelation activities of aged and fresh garlic extracts. Figure 4 showed the metal chelating 
effects of aged and fresh garlic extracts. Both extracts showed potent chelating abilities for ferrous ions. However, 
at all tested concentrations the fresh garlic had a stronger chelating effect compared to the aged garlic extract 
(Fig. 4). At higher concentrations (15–20 mg/mL), fresh garlic extracts showed significant (P < 0.05) chelat-
ing abilities for ferrous ions whereas aged garlic extract showed significant (P < 0.001) chelating effect com-
pared to ethylenediaminetetraacetic acid (EDTA). However, EDTA showed significantly (P < 0.001) stronger 
Fe2+ -chelation activity even at minimal concentrations of 0.1 mg/mL compared to aged and fresh garlic extracts.
Phenolic, flavonoid and flavonol compounds in aged and fresh garlic extracts.  Table 3 shows 
the concentration of total phenolic compounds was significantly (P < 0.001) higher in aged garlic compared to 
fresh garlic extract. Similarly, the total flavonoid and flavonol concentrations of aged garlic were significantly 
(P < 0.001) higher than fresh garlic extract (Table 3).
Discussion
There is considerable interest in antiglycation agents because of their therapeutic potential in reducing the mor-
bidity and mortality associated with diabetes. Different strategies have been proposed to reverse the effects of 
AGEs, focusing on inhibition of AGE formation, removal of AGEs or interference with cellular effects of AGEs2. 
This study showed both aged and fresh garlic extracts inhibit the formation of AGEs and is in agreement with 
previous studies demonstrating aged garlic extract and SAC effectively inhibit AGE formation in vitro12. Indeed, 
aged garlic extract was shown to have more potent antiglycation properties compared to fresh garlic extract. 
Moreover, the addition of SAC to fresh garlic extract increased the inhibition of AGEs (results not shown). In 
addition to SAC, other compounds may be present in aged garlic extract contributing towards its antiglycation 
activity, although these compounds have not yet been determined. Fresh and aged garlic extracts inhibited early 
glycation products (fructosamine) formation possibly by modification of carbonyl or amino groups in the glyca-
tion reaction.
Protein oxidation has a key role in AGE formation and together with glycation generate protein-bound carbonyl 
groups, which have been detected in human tissues13. Furthermore, reaction with dinitrophenylhydrazine (DNPH) 
is a standard method for detecting carbonyl groups and can be used to follow changes in protein oxidation14. 
In this study, free carbonyl groups were generated by treating BSA with a high concentration of methylglyoxal. 
Aged garlic extract was more potent than fresh garlic in inhibiting protein-bound carbonyl groups with the 
results being comparable to the positive control, aminoguanidine and consistent with previous studies for 
aminoguanidine14.
Another protein modification that may potentially lead to structural changes is the loss of protein thiol groups. 
The oxidation of thiol groups was observed following glycation of BSA and this was inhibited by aged garlic 
extract and protects against oxidative protein damage. Therefore, the thiol assay provides mechanistic informa-
tion concerning the effects of aged and fresh garlic extracts on AGEs.
Figure 4. Effects of aged and fresh garlic extracts on metal chelating capacity. Each value represents the 
mean ± SD (n = 6). Statistical significance was defined as *P < 0.05, **P < 0.01, ***P < 0.001 compared to fresh 
garlic extract at each tested concentration.
Total phenolics 
mg/g
Total flavonoids 
mg/g
Total flavonols 
mg/g
Aged garlic extract 129A ± 1.8 101A ± 1.8 94A ± 0.9
Fresh garlic extract 56B ± 1.2 47B ± 6 43B ± 3.3
Table 3.  Total amount of phenolic, flavonoid and flavonol compounds in aged and fresh garlic extracts.  
Data are presented as mean ± SD (n = 6). The symbol A refers to the significant difference between the labelled 
values as compared to the aged garlic extract. Labelled means in each column without common uppercase 
letters differ significantly from aged garlic extract, P < 0.001.
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Natural compounds with antioxidant properties can inhibit AGE formation. In this regard, compounds such 
as rutin15, garcinol16, loubuma tea17 and green tea18 have been shown to prevent AGE formation both in vitro 
and in vivo. Thus, the antiglycation activity of plant extracts could be attributed to their antioxidant properties. 
Indeed, several studies have demonstrated that the protective effects of garlic are due to their antioxidant and 
radical scavenging capacities19,20. The abilities of aged and fresh garlic extracts to scavenge ABTS˙ were compared 
with ascorbic acid, the latter being an excellent marker for determining the antioxidant capacity of hydrogen 
donating antioxidants. The higher scavenging activity of aged garlic compared to fresh garlic extract was deemed 
similar to the antioxidant capacity of ascorbic acid and may be related to the high polyphenolic content of aged 
garlic extract. Antioxidant compounds can also reduce the purple colour of DPPH˙ by providing hydrogen atoms 
or by electron donation and producing a colourless complex causing decreased absorbance, which is a measure of 
the extent of radical scavenging. The DPPH˙ scavenging activity of phenolic compounds in aged and fresh garlic 
extracts is mainly due to their redox properties and depends on the chemical structure of the compound, the 
number of hydroxyl groups, the substitution pattern of hydroxyl groups and on the method of analysis21.
In the metal chelation assay, ferrozine forms complexes with ferrous ions and, in the presence of ferrous 
chelating agents; the complex formation is disrupted, resulting in reduction of the red complex colour. Therefore, 
measurement of colour reduction reflects metal chelation activity of coexisting chelators22. Aged and fresh garlic 
extracts interfere with the formation of ferrous and ferrozine complexes, therefore are able to capture ferrous ions 
before formation of ferrozine and accordingly produce metal chelation activity. Unexpectedly, fresh garlic extract 
produced stronger ferrous chelation activity compared to aged garlic extract, although the latter had higher flavo-
noid content. The metal-chelating ability of aged and fresh garlic extracts depend on their phenolic structure and 
the number and position of hydroxyl groups. It may be that the flavonoids in aged garlic extract do not have the 
required structure, accounting for this result. In addition, it is believed that acidic and/or basic amino acids may 
play an important role in the chelation of metal ions.
Aged garlic extract, which contains the highest amount of phenolic, flavonoid and flavonol compounds, 
exhibited the greatest antioxidant activity. These results were in agreement with those of previous workers who 
reported that the total phenolic content of aged garlic extract was higher than that of fresh and steamed garlic 
extracts23. Flavonoids and flavonols are important natural phenolics, and are the most widespread group of nat-
ural compounds. The mechanism(s) of action of flavonoids and flavonols are through the scavenging or chelat-
ing process24. Findings of this study support the hypothesis that phenolic compound in certain plant extracts 
effectively inhibit the formation of AGEs. Indeed, compounds with phenolic, flavonoid and flavonols content 
effectively inhibited the formation of dicarbonyl compounds and AGEs25. Therefore, the difference in antioxidant 
and antiglycation activities between aged and fresh garlic extracts could be due to their composition of phenolic 
and/or other non-phenolic compounds.
The aging of garlic converts the harsh, unstable and irritating compounds found in raw garlic such as allicin to 
stable unique and beneficial compounds. Thus, the processing method of aging garlic may influence its antioxi-
dant activities. The high antioxidant activities of aged garlic extract might be due to antioxidant compounds other 
than phenolic compounds. The antiglycation activity of aged garlic extract is mainly due to its organosulphur 
compounds. Aged garlic extract contains mostly stable water-soluble organosulphur compounds such as SAC and 
SAMC, which are powerful antioxidants and are largely responsible for aged garlic extract’s health benefits. The 
pharmacokinetics of SAC is well established in vivo, which has high bioavailability and is used for standardizing 
aged garlic extract26. Both phenolic and organosulphur compounds present in garlic possess radical scavenging 
properties27. However, the presence of other potential antioxidant compounds, such as vitamin C, vitamin E and 
β -carotene, may also play an important role21. This antioxidant property of aged garlic extract may at least in part, 
account for its antiglycation properties.
This study has several limitations, one of which is the use of high sugar concentrations to speed up the gly-
cation reaction, which otherwise occurs slowly in vivo being dependent on degree and duration of glycaemia. 
However, such an approach is useful for mechanistic studies allowing them to be conducted in an acceptable 
timescale and reducing the possibility of microbial sample contamination. It is unclear how these extracts would 
be metabolized in vivo and whether the relevant active ingredients would be present in blood at appropriate con-
centrations or whether any synergistic effects would still be operational. However, the approach used does provide 
a simple screening process to assess antiglycation and antioxidant properties of interesting extracts.
Dietary supplementation with antioxidants may be a safe and simple way of complementing traditional ther-
apies aimed at targeting and preventing diabetic complications. This study demonstrates that aged and fresh 
garlic extracts protect against protein glycation in vitro. Aged garlic extract inhibits the formation of AGEs more 
effectively than fresh garlic extract, and this finding together with previous data suggest that daily consumption 
of aged garlic extract might be beneficial for prevention of lifestyle-related diseases. It is important to identify 
all compounds in aged garlic extract and to clarify their precise role. The bioavailability of different garlic com-
ponents and their ability to inhibit AGE formation require further investigation. Further research is needed to 
clarify whether aged garlic extract attenuates the development of diabetic vascular lesions in vivo.
Materials and Methods
Ethylenediaminetetraacetic acid was obtained from Fisher Scientific International, UK. Aged garlic extract 
was kindly provided by Wakunaga of America Company Ltd. Ribose, sodium dodecyl sulphate (SDS) and 
Tris (hydroxymethyl)-amino methane were obtained from BDH, UK. Acrylamide solution was obtained from 
Bio-Rad Laboratories (Hemel Hempstead, UK). Bromophenol blue was obtained from Serva, Germany. Ethanol, 
glacial acetic acid and methanol were obtained from Fisher Scientific International, UK. Dialysis tubing with a 
molecular weight cut off of 3.5 kDa and 67 kDa was obtained from Medical International Ltd Company (London, 
UK). Advanced glycation endproduct antibody (rabbit polyclonal to AGE antibody) and rabbit IgG secondary 
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antibody (goat polyclonal to rabbit IgG) were purchased from Abcam, UK. All other reagents were of analytical 
reagent grade from Sigma-Aldrich Company (Poole, UK).
Protein glycation. Briefly, either BSA or lysozyme (10 mg/mL) were incubated in 0.5 M glucose or 0.1 M 
methylglyoxal with or without prospective inhibitors (aged and fresh garlic extracts) in 0.1 M sodium phosphate 
buffer containing 3 mM sodium azide, pH 7.4 at 37 °C in the dark for a defined period of time12. Control samples 
with or without prospective inhibitors were incubated under the same conditions. Aliquots were stored at − 20 °C 
until analysis.
Preparation of fresh garlic extract. Fresh garlic was purchased from a retail food store (Manchester, UK). 
Garlic bulbs were identified by a botanist at the university. The bulbs (50 g) in good physical shape were peeled 
and weighed. Aqueous garlic extract was prepared according to an established method28. Briefly, 50 g of garlic was 
homogenized in 75 mL of cold 0.9% NaCl in the presence of some crushed ice. Homogenization was carried out 
in a blender at the highest speed with 1 minute bursts for a total of 12 minutes. The homogenized mixture was 
filtered through cheese cloth, centrifuged at 2000 × g for 10 minutes and the clear supernatant made up to 100 mL 
with saline. This aqueous garlic extract was stored in small aliquots at − 20 °C until use. The dose of fresh garlic 
was calculated on the basis of the weight of fresh garlic in mg used to prepare a 1 mL extract (one millilitre of 
aqueous extract contained material from 500 mg of garlic). The aqueous garlic extract contains about 50% garlic 
material.
Interrupted post-Amadori assay.  Ribose-glycated protein rich in Amadori adducts was prepared as 
described previously12. Briefly, BSA (10 mg/mL) was incubated in 0.5 M ribose in 0.1 M sodium phosphate buffer 
containing 3 mM sodium azide, pH 7.4 at 37 °C for 24-hours. Unbound sugar was removed by extensive dialysis 
against distilled water and this Amadori-rich protein reincubated with or without the prospective extract at 37 °C. 
Aliquots were taken at various intervals (0–8 days) and frozen for subsequent analysis before measurement of 
AGEs using the enzyme-linked immunosorbent assay (ELISA) below.
Measurement of fructosamine. Fructosamine content was quantified by a colorimetric method 
using nitroblue tetrazolium (NBT) as described previously29 and method calibrated using 1-deoxy-
1-morpholino-D-fructose (DMF) standards.
Measurement of AGEs. Crosslinked AGEs. These were assessed by the percentage crosslinking of the 
protein following sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) using 10% gels 
as described previously12. These gels were stained with Coomassie blue, destained, photographed and ana-
lyzed using Gene snap programme from G Box Chem HR16 and Gene tool image analysis software from Bio 
Tools, Inc. (Edmonton, Alberta, Canada), respectively. Integrated density (I.D) was measured to analyze the 
one-dimensional electrophoretic gels and percentage inhibition of cross-linked AGEs was calculated using the 
formula:
= × . − . .% inhibition 100 (I D without inhibitor I D with inhibitor)/I D without inhibitor
AGEs by ELISA. Microtiter plates were coated with 100 μ L of standards (1 ng/mL-1 mg/mL) and samples 
(1 μ g/mL) diluted in 50 mM carbonate buffer, pH 9.7, overnight at 4 °C. After coating, the wells were washed with 
300 μ L saline solution containing 0.05% Tween-20. The wells were treated with 200 μ L of blocking buffer (3–5% 
non-fat dry milk or 5% serum BSA) in sodium carbonate buffer or PBS for 2 hours at room temperature, followed 
by washing. A volume of 100 μ L of AGE antibody (rabbit polyclonal to AGE antibodies) as primary antibody was 
added at a suitable titre (1:2500 to 1:20000) diluted in blocking buffer and incubated for 2 hours at 37 °C, followed 
by washing. Then, 100 μ L of rabbit IgG antibody; goat polyclonal to rabbit IgG (horse radish peroxidase) as the 
secondary antibody was added at a titre of 1:4000 to 1:10000 diluted in blocking buffer immediately before use 
and incubated for 1 hour at 37 °C, followed by washing. ABTS diammonium salt substrate solution was added 
(100 μ L/well) to the plates followed by an incubation at room temperature for up to 30 minutes. A 100 μ L of stop 
solution (0.625 M oxalic acid) was added, mixed and absorbance determined at 450 nm.
Measurement of protein-bound carbonyl groups. Protein-bound carbonyl groups were measured 
using DNPH derivatisation as described previously30. The carbonyl content was calculated using a molar absorb-
ance of 22,000 M−1cm−1 and the results expressed as the ratio of nmoles of DNPH reacted per mg of protein.
Measurement of thiol groups. Free thiol content was determined in BSA alone and in glycated BSA 
in the presence or absence of extracts according to an established method31 using 5,5′ -dithiobisnitrobenzoic 
acid (DTNB) and L-cysteine hydrochloride as standards. Free thiol concentration was calculated using 
14,150 M−1cm−1 as the molar extinction coefficient of DTNB. The results were expressed as the ratio of nmoles of 
DTNB reacted per mg of protein.
ABTS antioxidant assay. The standard ABTS assay32 was used for determination of TEAC of both aged 
and fresh garlic extracts. Trolox dissolved in ethanol was used as a reference standard (0–20 μ M) whereas ascorbic 
acid was used as a positive control.
DPPH radical scavenging capacity assay. 1, 1-Diphenyl-2-picryl-hydrazyl radical scavenging activity 
of extracts was measured according to a modified version of an existing method33. Trolox was used as the ref-
erence standard compound and ascorbic acid was used as positive control. Antioxidant activity of a sample was 
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expressed in terms of micromole equivalents of trolox. The concentration causing 50% inhibition (IC50) of each 
extract was determined and compared with the corresponding TEAC.
Metal chelation assay. The ability of garlic extracts to chelate ferrous ions (Fe2+) was assessed according to 
a modified version of an established method34. EDTA was used as a positive control and diluted to 0.01–20 mg/mL 
for further use. The chelating activity of the extract for Fe2+ was calculated using the formula:
= − ×Chelating rate [1 (absorbance of the sample)/(absorbance of control)] 100
Measurement of total phenolic compounds. The amount of total phenolic compounds in garlic 
extracts was estimated according to a modified version of a previously reported method using Folin-Ciocalteu 
reagent35. The method was calibrated using 0.024–0.3 mg/mL ethanolic gallic acid solution (10 g/L) and results 
were expressed as milligrams per gram of extract of gallic acid equivalents.
Measurement of total flavonoids.  The flavonoid content was determined according to a modified version 
of a previously described colorimetric procedure using quercetin as a reference compound36. Quercetin was used 
for standards and the flavonoid content was expressed in milligrams of quercetin equivalent per gram of extract.
Measurement of total flavonols.  The content of flavonols was determined according to an established 
method35. Rutin standards were used to calibrate the method and flavonol content was expressed as milligrams of 
rutin equivalent per gram of extract.
Statistical analysis. Statistical analysis was performed using SPSS 19 software (SPSS Inc., Chicago, Illinois, 
USA). Data were presented as mean ± standard deviation (SD) from at least three independent experiments. The 
significant difference between test groups was analyzed using two-way analysis of variance (2-factor ANOVA), 
followed by Bonferroni Post Hoc tests for the comparisons between tested concentrations in aged and fresh garlic 
extracts. A Dunnett’s Post Hoc test was used to compare between aged and fresh garlic extracts against the con-
trol. Statistical significance was defined as *P < 0.05, **P < 0.01, ***P < 0.001.
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